We are live on ! Find out more
VV Manager

VV Manager Portfolio holdings

AUM $114M Turnover 0%
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+59.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$21.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALLO icon
1
Allogene Therapeutics
ALLO
$215M
$222M 87.16%
7,681,133
– –
2018 Q4
1 quarter
QTTB icon
2
Q32 Bio
QTTB
$253M
$21.4M 8.39%
42,825
– –
2018 Q4
1 quarter
STRO icon
3
Sutro Biopharma
STRO
$143M
$11.3M 4.45%
99,558
– –
2018 Q4
1 quarter

Similar funds

VV Manager's Q1 2019 Portfolio in Review

As of Q1 2019, VV Manager held 3 positions worth $255M, up 9.3% from $233M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. VV Manager opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • VV Manager's ten largest holdings make up 100% of its $255M portfolio in Q1 2019.
  • VV Manager opened 0 new positions and closed 0 in Q1 2019.
  • VV Manager's portfolio value rose 9.3% quarter-over-quarter to $255M.

Based on VV Manager's 13F filing for Q1 2019, filed 11 Apr 2019.